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Abstract
Objectives To describe the multicentre clinical databases that
exist in the United Kingdom, to report on their quality, to
explore which organisational and managerial features are
associated with high quality, and to make recommendations for
improvements.
Design Cross sectional survey, with interviews with database
custodians and search of electronic bibliographic database
(PubMed).
Studies reviewed 105 clinical databases across the United
Kingdom.
Results Clinical databases existed in all areas of health care, but
their distribution was uneven—cancer and surgery were better
covered than mental health and obstetrics. They varied greatly
in age, size, growth rate, and geographical areas covered. Their
scope (and thus their potential uses) and the quality of the data
collected also varied. The latter was not associated with any
organisational characteristics. Despite impressive achievements,
many faced substantial financial uncertainty. Considerable
scope existed for improvements: greater use of nationally
approved codes; more support from relevant professional
organisations; greater involvement by nurses, allied health
professionals, managers, and laypeople in database
management teams; and more attention to data security and
ensuring patient confidentiality. With some notable exceptions,
the audit and research potential of most databases had not
been realised: half the databases had each produced only four
or fewer peer reviewed research articles.
Conclusions At least one clinical database support unit is
needed in the United Kingdom to provide assistance in
organisation and management, information technology,
epidemiology, and statistics. Without such an initiative, the
variable picture of databases reported here is likely to persist
and their potential not be realised.
Introduction
The need for high quality, multicentre databases that provide
information about the use of health services has been
thoroughly documented.1–4 Briefly, they offer the opportunity to
carry out evaluative research5 and clinical audit,6 to inform the
planning and management of services,7 and to provide
individual clinicians with accurate estimates of the outcome of
their care (assuming an accurate prognostic model exists) that
can be shared with patients.8 Despite their considerable potential,
many multicentre clinical databases in Britain remain under-
used. This is because of a widespread lack of awareness of what
databases exist and scepticism about their quality. Previous over-
views of such databases have either not attempted to be compre-
hensive or not tried to provide independent reviews of quality.9
In addition, little is known as how best to establish a good data-
base, despite proposals that factors such as the involvement of
epidemiologists and statisticians may be beneficial.9
In 2001 we created the Directory of Clinical Databases
(www.docdat.org), which allows, for the first time, access to
descriptions of the clinical databases that exist in the United
Kingdom, including independent reports of their quality, and
allows us to explore which organisational and managerial
features of databases are associated with high quality and to
make recommendations for improvements.10 11
Methods
Directory of Clinical Databases (DoCDat)
Inclusion is restricted to those databases that have information
on the recipients of health care. We exclude databases in which
information is limited to the provision of resources or services,
such as a register of hospital bed provision, useful though such
data are in studying and managing health services. We include
databases that meet the following criteria (whether based on data
collected retrospectively or prospectively):
x Provision of individual level data (whether or not users of the
database are permitted to know patients’ identities)
x Inclusion in the database is defined by a common
circumstance (such as patient’s condition or intervention
required or undergone (which might be a diagnostic test,
treatment, or a collection of interventions such as intensive
care)); by an administrative arrangement (such as registered with
a general practitioner, target for immunisation, subscriber to
health insurance); or by an adverse outcome (such as maternal
death)
x Data from more than one healthcare provider are included
(usually many providers in a region or country).
We identified databases through inquiries to government
health departments, royal colleges and specialist associations,
and pharmaceutical companies; searches of previous reviews,
research publications, and the internet; and word of mouth. Each
entry was based on an in depth interview (usually by telephone)
with the custodian of the database. Interviews lasted 30-60 min-
utes and followed a structured format. The principal aspects
included were the geographical area covered, the length and
periodicity of data collection, the number of patients or episodes
collected to date, the use of nationally approved NHS codes,
linkage to other databases, security and confidentiality of the
data, the feasibility of ad hoc analyses, use of the data for audit
and research, approval from professional bodies, the composi-
tion of any management team, and sources of funding.
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In addition, the interviewer independently assessed
10 aspects of database quality using a tested instrument.9 Five of
these relate to data quality (completeness of recruitment,
completeness of data, use of explicit definitions for variables,
independence of observations of outcomes, and extent to which
data are validated). The interviews were supplemented by an
analysis of a bibliographic database (PubMed) to ascertain the
number of research papers in peer reviewed journals that had
made use of the databases.
Analysis of databases
We included all 105 databases for which a full entry existed in
DoCDat in August 2003. We analysed the databases to describe
the clinical areas they covered, their organisation and
management, how data security and confidentiality were
managed, what the databases were used for, and the quality of
the data, and to explore any associations between characteristics
of databases and the five dimensions of data quality. We tested
the statistical significance of any associations with the 2 test.
Results
Clinical areas covered by existing databases
The clinical subject most commonly covered by the 105
databases was cancer (see box). While the 11 general databases,
mostly regional and national cancer registries, were well known,
there were 14 less well known specialised ones. Like many data-
bases in other clinical areas, these were mostly developed by
enthusiastic individuals rather than by national organisations.
The next most common subjects covered were surgery (15 data-
bases), congenital anomalies (14), and trauma and intensive care
(9). Among the 23 databases for medical conditions, diabetes and
cardiovascular conditions predominated. In contrast, only three
databases related to maternity care, and only four related to
mental health.
Organisation and management of databases
Most of the databases (66%) covered one or more UK nations
(England, Scotland, Wales, Northern Ireland) (table 1). The rest
were restricted to a region of one of these countries. Most (81%)
had collected data continuously since being established, while
most of the rest had been set up for a one off period.
Although half the databases used nationally approved codes
to identify patients (that is, the NHS number), less than a third
used approved institutional codes, and only 16% used clinician
codes. A third had obtained explicit approval from the relevant
clinical or professional body, such as a royal college.
The group or teammanaging a database varied in size and in
composition. While almost all included doctors (95%), only 42%
included nurses, and 26% included allied health professionals
(such as physiotherapists). Most recognised the need for techni-
cal and methodological input from epidemiologists (69%), statis-
ticians (79%), and information technology specialists (63%). In
contrast, only a minority saw a need for representation from
managers (32%) and laypeople (24%).
Funding came from a variety of sources. Most received some
funds from the public sector (mainly the Department of Health
or the NHS), though sometimes this was only pump priming to
get the database established. Three other sources—private sector,
subscriptions from participating healthcare providers, and
charities—each provided finance for 10-20%. A few databases
(5%) reported no funding. The distribution of funding partly
reflects the absence from DoCDat of databases owned by private
companies, despite our attempts to include them.
Number and examples of clinical databases by clinical
area
General (9 databases)
For example:
Hospital Episode Statistics
General Practice Research Database
MRC National Survey of Health and Development
Cancer (general) (11 databases)
For example:
National Registry of Childhood Tumours
Northern Ireland Cancer Registry
North West Cancer Registry
Cancer (specialised) (14 databases)
For example:
Scotland and Newcastle Lymphoma Group
Assessment of Stomach and Oesophageal Cancer
British Association of Surgical Oncology—Breast Unit Database
Surgical procedures (15 databases)
For example:
UK Hydrocephalus Shunt Registry
National Adult Cardiac Surgical Database
North West Arthroplasty Register
Infectious diseases (3 databases)
National Prospective Monitoring Scheme on HIV
Nosocomial Infection National Surveillance Scheme
UK Register of HIV Seroconverters
Congenital anomalies (14 databases)
For example:
Oxford Register of Early Childhood Impairments
Trent Congenital Anomalies Register
Glasgow Register of Congenital Anomalies
Maternity (3 databases)
For example:
St Mary’s Maternity Information System
Confidential Enquiry into Maternal and Child Health
Trauma and intensive care (9 databases)
For example:
Intensive Care National Audit and Research Centre—Case Mix
Programme Database
Trauma Audit and Research Network
All Wales Injury Surveillance System
Diabetes (6 databases)
For example:
UK Diabetes Information and Benchmarking System
Quality Indicators in Diabetes Service
National Paediatric Diabetes Audit
Cardiovascular disease (7 databases)
For example:
National Sentinel Audit of Stroke
Myocardial Infarction National Audit Programme
National Pacemaker Database
Respiratory disease (3 databases)
UK Cystic Fibrosis Database
Chronic Obstructive Pulmonary Disease 2001 Audit
Scottish Asthma Management Initiative
Other medical conditions (7 databases)
For example:
Northern Region Haematology Register
Scottish Motor Neurone Disease Register
UK National Renal Registry
Mental health (4 databases)
For example:
Functional Analysis of Care Environments
Carers and Users Expectations of Mental Health Services
National Drug Treatment Monitoring System
Information in practice
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Five of the databases were established over 50 years ago
(table 2), four being cancer registries and one a longitudinal birth
cohort. However, most databases were much more recent, with
over half starting since 1990. While there is evidence that the
establishment of new databases has accelerated in recent years,
our figures refer only to those still functioning in 2003. It is likely
that some databases established in earlier decades have since
stopped, giving an underestimate of the incidence of new ones in
that period. Information for the most recent years is also likely to
be an underestimate because of delays in identifying new
databases.
The databases varied considerably in size, from data on a few
hundred patients or episodes of care to over 130 million (table
2). Not surprisingly, smaller databases tended to have been
established more recently: the five smallest had all started in the
previous five years. The three largest databases recorded hospital
admissions for an entire country (Hospital Episode Statistics,
Scottish Morbidity Record, and Patient Episode Database for
Wales). The growth rate of databases with continuous
recruitment also varied considerably. Five databases acquired
fewer than 100 patients or episodes of care a year. These tended
to cover rare conditions (such as acromegaly or motor neurone
disease). In contrast, the national hospital inpatient databases
accumulated more than half a million new episodes a year.
Security and confidentiality of data
Most databases (71%) stored their data on a computer connected
to an external network, albeit with robust firewalls to prevent
intruders (table 3). Back up versions of the database were usually
on disks or CD Roms (65%), although 30% of databases backed
up to another computer with external connections. Almost 60%
also retained data on paper forms.
Ideally, data should be reversibly anonymised (by using key
codes), so as to minimise the risk of disclosing individual identi-
ties12 but to maximise possible use of the database.13 This was true
for only 33%. Of the remainder, 12% were irreversibly
anonymised and 55% contained patient identifiers. For most
databases (72%), the patients had not been informed that
personal data were being collected, and for 88%, signed consent
was not obtained.
Uses of databases
Irrespective of the purposes for which the databases were estab-
lished, most could be used for all four of the principal
applications cited in the introduction.Most (75%) allowed ad hoc
analyses to be conducted centrally, where the data were
aggregated and stored, but only 58% allowed such analyses to be
Table 1 Organisation and management of 105 clinical databases with full
entry in DoCDat, August 2003
Features No (%) of databases
Geographical area covered:
Two or more UK nations 45 (43)
One nation 24 (23)
Regional 36 (34)
Time frame for data collection:
Continuous 85 (81)
Periodic 4 (4)
One off 16 (15)
Use of nationally approved codes:
Patient codes 50 (48)
Clinician codes 17 (16)
Institution codes 30 (29)
Routinely linked to other databases 49 (47)
Approval by clinical or professional body 36 (34)
Composition of database management team:
Doctors 100 (95)
Nurses 44 (42)
Allied health professionals 27 (26)
Epidemiologists 72 (69)
Statisticians 83 (79)
Information technologists 66 (63)
General managers 34 (32)
Laypeople 25 (24)
Funding:
Public sector 76 (72)
Private sector 13 (12)
Provider subscriptions 12 (11)
Charity 19 (18)
None 5 (5)
Table 2 Age, size, and rate of growth of 105 clinical databases with full
entry in DoCDat, August 2003
Characteristics No (%) of databases
Year established
Before 1960 5 (5)
1960-9 6 (6)
1970-9 16 (15)
1980-9 14 (13)
1990-4 17 (16)
1995-9 29 (28)
2000 onward 8 (8)
Size (No of patients or episodes):
<2000 15 (14)
2000-9999 27 (26)
10 000-49 999 25 (24)
50 000-1 million 26 (25)
>1 million 12 (11)
Growth rate (new patients or episodes/year)*:
<100 5 (6)
100-499 15 (18)
500-1999 23 (27)
2000-9999 16 (19)
10 000-49 999 17 (20)
50 000-499 999 6 (7)
>500 000 3 (4)
*Based on 85 databases with continuous recruitment.
Table 3 Security and confidentiality of 105 clinical databases with full entry
in DoCDat, August 2003
Characteristics No (%) of databases
Data storage:
Stand alone computer 30 (29)
Connected to external network 75 (71)
Back up data storage:
Stand alone computer 5 (5)
Connected to external network 32 (30)
Disks or CDs 68 (65)
Paper forms stored 62 (59)
Confidentiality:
Irreversibly anonymised 13 (12)
Reversibly anonymised 34 (32)
Identifiable 58 (55)
Patients informed of data collection:
Individually informed 23 (22)
Collectively informed 6 (6)
Not informed 76 (72)
Patient consent for data collection:
Signed consent 12 (11)
No signed consent but opt out 10 (10)
No signed consent or opt out 83 (79)
Information in practice
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conducted locally by the providers of the data (table 4). Of the 95
databases that identified the healthcare providers, 40% produced
audit reports on individual providers, but only 29% provided
multicentre comparative reports.
The use of databases for research was also patchy. About a
third were unable to provide a bibliography of peer reviewed
journal articles based on use of their database. Our search of
PubMed revealed that about a quarter of the databases had not
been used for any articles and a further quarter had been used in
fewer than five articles each. In contrast, eight databases had each
been the basis of over 100 articles. These data probably under-
estimate the research output as PubMed does not facilitate
searches by database name and some authors may fail to
mention the database they used. In addition, some articles may
have appeared in journals not indexed by PubMed, and some
recently established databases would not be expected to have
generated any research output yet. However, we may also have
overestimated the output as some articles, while authored by
database custodians and associates, may not have made use of
the database in question.
Quality of the data
We measured the quality of the data in the databases against five
criteria (table 5). Over half (57%) of the databases recruited at
least 90% of eligible people or episodes. This underestimates the
true prevalence of good databases, because up to a third of data-
base custodians did not know their recruitment proportion.
Similarly, over 40% did not know the level of completeness of
their data. Of those that did, about 70% reported high levels of
completeness.
About half the databases did not use explicit definitions for
most of the variables collected. Of the 94 databases that included
an outcome variable, 64% either used an independent, blinded
observer (that is, one who was unaware of the intervention
undergone) or this was unnecessary as the outcome was
objective (usually survival). The data in almost all databases
(92%) were subjected to range and consistency checks. In 27%
some form of external validation (such as comparison with
medical records) was also conducted.
Associations between characteristics of databases and data
quality
Only one of the eight organisational characteristics we examined
was significantly associated with database quality (table 6):
databases that informed patients they were being included were
more likely to have complete data. Given that 40 associations
were tested, one statistically significant one (at P = 0.016) may
have occurred by chance. Seven other associations were
significant at the 10% level (P = 0.1): national databases were
associated with better validation but poorer assessment of
outcome than regional databases; approval from a professional
body was associated with better validation; routine linkage was
associated with better recruitment and validation; and having an
epidemiologist or statistician in the management team was asso-
ciated with better recruitment and validation.
Discussion
We found multicentre clinical databases in all areas of UK health
care, though their distribution was uneven—cancer and surgery
were better covered than mental health and obstetrics. They var-
ied greatly in age, size, growth rates, and the geographical areas
they covered. Their scope (and thus their potential uses) and the
quality of the data collected also varied. The latter was not associ-
ated with any organisational characteristics. Despite impressive
achievements, many faced considerable financial uncertainty.
Considerable scope exists for improvements: greater use of
nationally approved codes; more support from relevant
professional organisations; greater involvement by nurses, allied
health professionals, managers, and laypeople in database man-
agement teams; and more attention to data security and
ensuring patient confidentiality (something that most database
custodians are currently addressing in meeting the requirements
of the Patient Information Advisory Group14). With some
notable exceptions, the audit and research potential of most of
the databases was not being realised.
Study limitations
Although this review provides critical information on UK clinical
databases for the first time, it is limited in three ways. Firstly, we
may have missed some key databases. In particular, those
included were restricted to the public sector, despite our
attempts to gain access to information about databases held by
Table 4 Uses of 105 clinical databases with full entry in DoCDat, August
2003
Uses No (%) of databases
Ad hoc analyses for providers:
Possible locally (n=103) 61 (58)
Possible centrally (n=105) 79 (75)
Audit reports:
Provider-specific (n=95) 42 (40)
Multicentre (n=95) 28 (27)
Research (No of papers* based on database):
None 28 (27)
1-4 24 (23)
5-9 12 (11)
10-29 21 (20)
30-99 12 (11)
≥100 8 (8)
*Papers published in peer reviewed journals.
Table 5 Quality of data in 105 clinical databases with full entry in DoCDat,
August 2003
Quality criteria No (%) of databases
Completeness of recruitment:
Few (<80%) or unknown 36 (34)
Some (80-89%) 9 (9)
Most (90-97%) 16 (15)
All or almost all (>97%) 44 (42)
Completeness of data:
Few (<80%) or unknown 44 (42)
Some (80-89%) 19 (18)
Most (90-97%) 23 (22)
All or almost all (>97%) 19 (18)
Use of explicit definitions of variables:
None 41 (39)
Some (<50%) 10 (10)
Most (50-97%) 16 (15)
All or almost all (>97%) 38 (36)
Independence of observations of primary outcome:
Outcome not included 11
Observer neither independent nor blinded 23/94 (24)
Independent observer not blinded 11/94 (12)
Independent observer blinded or outcome is objective 60/94 (64)
Extent of data validation:
No validation 3 (3)
Range or consistency checks 5 (5)
Range and consistency checks 69 (66)
Range and consistency checks plus external check 28 (27)
Information in practice
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pharmaceutical companies. Secondly, our information was
largely self reported by database custodians. Despite careful
interrogation, some accounts may be unjustifiably favourable.
Thirdly, the lack of statistically significant associations between
organisational characteristics and data quality (with one
exception) may reflect the small sample size.
Implications of results
Considerable effort and resources are expended by clinicians,
methodologists, computing staff, and others to create and main-
tain clinical databases in Britain. Many database custodians work
in isolation with little contact or support from others engaged in
similar activities. The need for improvements in database organi-
sation, data quality, and data use is widely recognised among
these highly committed individuals and groups. The inception, in
March 2003, of a forum for database custodians to exchange
experiences and help one another has both highlighted these
needs and started to meet them. However, without resources to
promote and support the development of databases, such meas-
ures can have only limited impact.
Just as clinicians are not expected to be able to organise and
carry out randomised trials without the support of clinical trials
units, so we should not expect high quality databases to be devel-
oped without some dedicated specialised support. This could be
met by the establishment of at least one clinical database support
unit. This could provide advice and assistance in organisation
and management, information technology, epidemiology, and
statistics. Without such an initiative, the variable picture of data-
bases reported here is likely to persist, and their potential will not
be realised.
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Table 6 Association between eight organisational characteristics of 105 clinical databases with full entry in DoCDat, August 2003, and five quality criteria.
(Values are relative risk of characteristic being associated with good quality*)
Organisational characteristics
Quality criteria
Recruitment Completeness of data Explicit definitions Independent outcomes Validation
National coverage (v regional) 0.98 0.77 1.15 0.80 1.88
Continuous or periodic data collection
(v one off)
1.16 1.72 0.91 1.25 1.47
Patients informed of data collection
(v not informed)
1.30 1.79† 0.83 1.09 1.24
Approval by professional body (v none) 0.82 1.08 1.04 1.03 1.64
Linkage to other databases (v none) 1.30 0.80 1.24 1.16 1.75
Membership of management team
(v none):
Epidemiologist or statistician 1.58 0.85 1.13 0.86 1.87
General manager 1.31 0.93 1.04 1.08 0.96
Layperson 0.97 0.74 1.02 0.79 0.53
*Definitions of good quality. Recruitment: ≥90% of eligible population recruited to database. Completeness of data: 80% of variables 95% complete. Explicit definitions: 50% of variables have
explicit written definition. Independent outcomes: independent observer blinded to intervention or objective outcome. Validation: range and consistency checks.
†P=0.016.
What is already known on this topic
High quality clinical databases can support
evaluative research, audit, clinical management,
and planning of services
There is a widespread lack of awareness of what
databases exist in the United Kingdom, scepticism
about their quality, and uncertainty as to the
extent to which they are used
What this study adds
UK clinical databases exist in all areas of health
care, varying greatly in age, size, geographical area
covered, scope, and quality
The audit and research potential of many
databases is not being realised
Considerable scope exists for improvements,
which could be facilitated by a dedicated national
support unit
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